PHAR vs AMGN: Which Stock is Better?
Side-by-side comparison of Pharming Group Nv and Amgen Inc in 2026
PHAR
Pharming Group Nv
$17.34
AMGN
Amgen Inc
$355.30
Key Metrics Comparison
| Metric | PHAR | AMGN | Winner |
|---|---|---|---|
| Market Cap | $1.22B | $188.34B | AMGN |
| P/E Ratio | 433.25 | 24.57 | AMGN |
| EPS (TTM) | $0.04 | $14.22 | AMGN |
| Revenue Growth | 0.1% | 0.1% | PHAR |
| Gross Margin | 87.9% | 70.8% | PHAR |
Analyze PHAR
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHAR or AMGN a better investment?
Comparing PHAR and AMGN: Pharming Group Nv has a market cap of $1.22B while Amgen Inc has $188.34B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHAR and AMGN?
PHAR (Pharming Group Nv) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHAR or AMGN?
Based on P/E ratios, AMGN trades at a lower multiple (24.6x vs 433.3x).
Which is growing faster: PHAR or AMGN?
PHAR has higher revenue growth at 0.1% vs 0.1% for AMGN.
Which company is more profitable: PHAR or AMGN?
Pharming Group Nv (PHAR) has higher gross margins at 87.9% compared to 70.8% for AMGN.
Which is the larger company: PHAR or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $188.34B compared to $1.22B for PHAR.
Should I buy PHAR or AMGN in 2026?
Both PHAR and AMGN have investment merit. PHAR trades at $17.34 while AMGN trades at $355.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHAR and AMGN stock?
Key differences: Market Cap ($1.22B vs $188.34B), P/E Ratio (433.3x vs 24.6x), Revenue Growth (0.1% vs 0.1%), Gross Margin (87.9% vs 70.8%).